These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

753 related articles for article (PubMed ID: 24057291)

  • 1. Circulating irisin in relation to insulin resistance and the metabolic syndrome.
    Park KH; Zaichenko L; Brinkoetter M; Thakkar B; Sahin-Efe A; Joung KE; Tsoukas MA; Geladari EV; Huh JY; Dincer F; Davis CR; Crowell JA; Mantzoros CS
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4899-907. PubMed ID: 24057291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of circulating irisin with metabolic risk factors in Chinese adults: a cross-sectional community-based study.
    Tang L; Tong Y; Zhang F; Chen G; Zhang YC; Jobin J; Tong N
    BMC Endocr Disord; 2019 Dec; 19(1):147. PubMed ID: 31881940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship of irisin with metabolic syndrome components and insulin secretion and resistance in schoolchildren.
    Wu CZ; Chu NF; Chang LC; Cheng CW; Lin YF; Pei D; Fang TC; Chen JS
    Medicine (Baltimore); 2021 Feb; 100(5):e24061. PubMed ID: 33592858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irisin is a biomarker for metabolic syndrome in prepubertal children.
    Shim YS; Kang MJ; Yang S; Hwang IT
    Endocr J; 2018 Jan; 65(1):23-31. PubMed ID: 28904307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of serum irisin with metabolic syndrome in obese Chinese adults.
    Yan B; Shi X; Zhang H; Pan L; Ma Z; Liu S; Liu Y; Li X; Yang S; Li Z
    PLoS One; 2014; 9(4):e94235. PubMed ID: 24709991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of circulating irisin levels with metabolic and metabolite profiles of Korean adolescents.
    Jang HB; Kim HJ; Kang JH; Park SI; Park KH; Lee HJ
    Metabolism; 2017 Aug; 73():100-108. PubMed ID: 28732566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between circulating irisin, retinol binding protein-4, adiponectin and inflammatory mediators in patients with metabolic syndrome.
    Tabak O; Simsek G; Erdenen F; Sozer V; Hasoglu T; Gelisgen R; Altunoglu E; Muderrisoglu C; Senyigit A; Uzun H
    Arch Endocrinol Metab; 2017 Dec; 61(6):515-523. PubMed ID: 28977161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Irisin in patients with nonalcoholic fatty liver disease.
    Polyzos SA; Kountouras J; Anastasilakis AD; Geladari EV; Mantzoros CS
    Metabolism; 2014 Feb; 63(2):207-17. PubMed ID: 24140091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High circulating irisin levels are associated with insulin resistance and vascular atherosclerosis in a cohort of nondiabetic adult subjects.
    Sesti G; Andreozzi F; Fiorentino TV; Mannino GC; Sciacqua A; Marini MA; Perticone F
    Acta Diabetol; 2014 Oct; 51(5):705-13. PubMed ID: 24619655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated circulating levels of an incretin hormone, glucagon-like peptide-1, are associated with metabolic components in high-risk patients with cardiovascular disease.
    Yamaoka-Tojo M; Tojo T; Takahira N; Matsunaga A; Aoyama N; Masuda T; Izumi T
    Cardiovasc Diabetol; 2010 May; 9():17. PubMed ID: 20470376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased irisin versus reduced fibroblast growth factor1 (FGF1) in relation to adiposity, atherogenicity and hematological indices in metabolic syndrome patients with and without prediabetes.
    Saber GY; Kasabri V; Saleh MI; Suyagh M; Halaseh L; Jaber R; Abu-Hassan H; Alalawi S
    Horm Mol Biol Clin Investig; 2019 Mar; 38(1):. PubMed ID: 30840586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inter-relationships between the severity of metabolic syndrome, insulin and adiponectin and their relationship to future type 2 diabetes and cardiovascular disease.
    DeBoer MD; Gurka MJ; Morrison JA; Woo JG
    Int J Obes (Lond); 2016 Sep; 40(9):1353-9. PubMed ID: 27133621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive analysis of circulating adipokines and hsCRP association with cardiovascular disease risk factors and metabolic syndrome in Arabs.
    Abu-Farha M; Behbehani K; Elkum N
    Cardiovasc Diabetol; 2014 Apr; 13():76. PubMed ID: 24716628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High irisin levels in overweight/obese children and its positive correlation with metabolic profile, blood pressure, and endothelial progenitor cells.
    De Meneck F; Victorino de Souza L; Oliveira V; do Franco MC
    Nutr Metab Cardiovasc Dis; 2018 Jul; 28(7):756-764. PubMed ID: 29858156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levels of circulating selenoprotein P, fibroblast growth factor (FGF) 21 and FGF23 in relation to the metabolic syndrome in young children.
    Ko BJ; Kim SM; Park KH; Park HS; Mantzoros CS
    Int J Obes (Lond); 2014 Dec; 38(12):1497-502. PubMed ID: 24638201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D modifies the associations between circulating betatrophin and cardiometabolic risk factors among youths at risk for metabolic syndrome.
    Fu J; Hou C; Li L; Feng D; Li G; Li M; Li C; Gao S; Li M
    Cardiovasc Diabetol; 2016 Oct; 15(1):142. PubMed ID: 27716289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin Resistance-Related Cardiometabolic Risk Among Nondiabetic Childbearing Age Females.
    Hewage N; Wijesekara U; Perera R
    Metab Syndr Relat Disord; 2024 Aug; 22(6):447-453. PubMed ID: 38603585
    [No Abstract]   [Full Text] [Related]  

  • 18. Differential impact of serum glucose, triglycerides, and high-density lipoprotein cholesterol on cardiovascular risk factor burden in nondiabetic, obese African American women: implications for the prevalence of metabolic syndrome.
    Gaillard T; Schuster D; Osei K
    Metabolism; 2010 Aug; 59(8):1115-23. PubMed ID: 20051282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HOMA-Adiponectin Closely Associates with Cardiometabolic Risk Markers in Middle-Aged Indians with Metabolic Syndrome.
    Banerjee J; Dhas Y; Mishra N
    Exp Clin Endocrinol Diabetes; 2021 Jun; 129(6):449-456. PubMed ID: 32189318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise.
    Huh JY; Panagiotou G; Mougios V; Brinkoetter M; Vamvini MT; Schneider BE; Mantzoros CS
    Metabolism; 2012 Dec; 61(12):1725-38. PubMed ID: 23018146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.